- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Varian releases planning tool
Radiotherapy giant Varian Medical Systems has begun marketing its latest treatment planning software for brachytherapy.
Radiotherapy giant Varian Medical Systems has begun marketing its latest treatment planning software for brachytherapy. VariSeed 7.0 helps physicians accurately deliver precise doses by providing access to real-time images generated during the implantation of radioactive seeds. The use of these seeds to treat prostate cancer has become increasingly common, producing results comparable to radical prostatectomy but with a lower risk of side effects such as impotence and incontinence. With VariSeed 7.0, radiation oncologists can generate a treatment plan, use it to implant the seeds, and see how the radiation dose will develop within the patient's anatomy while the patient is still in the operating room. This allows for fine-tuning and more precise adjustments on the spot, according to the company. VariSeed 7.0 also introduces the ability to superimpose different kinds of diagnostic images; SPECT, for example, can demonstrate the extent of disease, while CT and ultrasound show anatomy and positioning.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
